Medications

Added benefit of linagliptin is not proven

Linagliptin (trade name: Trajenta) has been approved since August 2011 to improve blood glucose control ("glycaemic control") in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled ...

Neuroscience

Many multiple sclerosis patients considering stem cell transplant

(HealthDay)—Many multiple sclerosis (MS) patients are considering autologous hematopoietic stem cell transplantation (aHSCT) as a treatment option, according to a study published in the January 2020 issue of Multiple Sclerosis ...

Neuroscience

New study focuses on improving cognitive symptoms of lupus

A National Jewish Health led study recently published in Lupus finds that technology using video game-based cognitive therapy improves attention and executive functioning in patients with systemic lupus erythematosus (SLE).

page 13 from 40